Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Ellipsys Vascular Access System Post Market Surveillance (PS) Study

ClinicalTrials.gov ID: NCT04484220

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT04484220. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 18, 2026, 4:06 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Ellipsys Vascular Access System Post Market Surveillance (PS) Study PS200001 Reference DEN170004

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The proposed clinical study is a prospective, non-randomized, multi-center, single-arm, observational, post-market surveillance (PS) study of the Ellipsys Vascular Access System in subjects eligible for arteriovenous (AV) fistula.

Study identification

NCT ID
NCT04484220
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Medtronic Endovascular
Industry
Enrollment
142 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 13, 2021 (Actual)
Primary completion
Mar 31, 2025 (Actual)
Completion
Mar 31, 2025 (Actual)
Last update posted
Jun 1, 2026

2021 – 2025

United States locations

U.S. sites
12
U.S. states
10
U.S. cities
11
Facility City State ZIP Site status
Nephrology Associates Access Center Riverside California 92501 —
Yale University New Haven Connecticut 06510 —
Azura Vascular Care, Jacksonville Jacksonville Florida 32218 —
Coastal Vascular and Interventional, PLLC Pensacola Florida 32504 —
Rush University Medical Center Chicago Illinois 60607 —
The Vascular Care Group Hyannis Massachusetts 022601 —
Nephrology Kidney Disease Hypertension Center Las Vegas Nevada 89128 —
Staten Island Hospital Staten Island New York 10305 —
University of Pittsburg Medical Center Pittsburgh Pennsylvania 15213 —
STAR Vascular Access Center San Antonio Texas 78207 —
San Antonio Kidney Disease Center San Antonio Texas 78216 —
Richmond Vascular Center North Chesterfield Virginia 23236 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04484220, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2026 · Synced Nov 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.